Researchers have developed a compound that can target and break down a post-transitionally modified protein associated with Alzheimer's disease.
Afimetoran, a newly developed pill to treat lupus, not only prevents lupus-like symptoms in mice, it also reverses signs of organ damage caused by the disease and prevents death. The medication is now undergoing phase 2 clinical trials to assess its effectiveness in lupus patients.
Researchers developed polymeric micelles of butyrate, a bacterial compound made by healthy a microbiome, that is effective against peanut allergies in mice.
A newly designed "smart pillow" that tracks the position of the head during sleep could help to track and monitor sleep quality and duration in those with sleep disorders.
Researchers report they have successfully translated the structure of a spider's web into music. The new study could provide new avenues for the development of 3D printing technologies and novel musical compositions. The findings also shed light on cross-species communication.
Researchers have developed a new biosensor that can detect SARS-CoV-2, the virus that leads to COVID-19, from nasopharyngeal swabs in under one minute.
Cannabigerol (CBG), a non-psychoactive cannabis compound, has antibiotic potential. Treating mice with MRSA, CBG worked as well as vancomycin, a powerful antibiotic, for treating the infection.
Fluoxetine rearranges nerve fibers in the hippocampus of mice, a new study reports.
Researchers have developed a compound that blocks the FKBP51 protein, which helps reduce chronic pain, provides positive outcomes for diet-induced obesity and improves symptoms of depression.
Researchers have developed smart sleepwear, embedded with self-powered sensors, which monitor heart rate, sleep posture and breathing. The technology will provide useful information to researchers, as well as the general public, to help improve sleep patterns.
An experimental treatment can generate immune cells that migrate to the brain and prevent attacks against myelin, allowing mice the ability to regain walking skills.
Researchers identify three distinct phases of MAO activity in Alzheimer's and suggest MAO could potentially be a helpful biomarker in diagnosing the disease.
